Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares U.S. Healthcare ETF (NY: IYH )

59.60 -0.13 (-0.22%)
Streaming Delayed Price Updated: 1:34 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares U.S. Healthcare ETF

< Previous 1 2 Next >
Intuitive Surgical Stock Hits All-Time High After Prelim Q4 Results Outpace Expectations: Retail Goes All In
Intuitive said worldwide da Vinci procedure volumes grew 18% in Q4 and 17% in 2024, driven by U.S. general surgery and international cancer procedures. 
Via Stocktwits
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million. 
Via Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase. 
Via Benzinga
Topics ETFs
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency. 
Via Benzinga
Topics Government
Exposures Political Product Safety
What Lies In Store For Healthcare ETFs In Q3 Earnings?
The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited. 
Via Talk Markets
Topics ETFs
Deere, Amgen, Copart And More: CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company as his final trade. 
Via Benzinga
Defensive ETFs Shine Amid A Rough Start To September
U.S. stocks started September on a dismal note on economic slowdown concerns following weak data, which shows that manufacturing shrank again in August. 
Via Talk Markets
Topics ETFs
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
Via Benzinga
Delta Air Lines, Interactive Brokers And More: CNBC's 'Final Trades'
Delta shares fell 3.5% to close at $43.83 on Monday. It struggles to recover from the cyber outage that impacted operations last week. 
Via Benzinga
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers. 
Via Benzinga
Topics Government
Exposures Political
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
You don't need to be a stock market expert to earn above-average returns. 
Via The Motley Fool
'Barbarism:' AOC Unleashes Fury On US Healthcare System As People Are 'Choosing Between Medicine And Rent'
America has one of the highest healthcare costs in the world, with healthcare spending hitting $4.5 trillion in 2022. 
Via Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
Via Talk Markets
Topics ETFs
Target, Apollo Global Management, Las Vegas Sands And More: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors named Apollo Global Management, Inc. 
Via Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.  
Via Benzinga
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc (NYSE: SHAK) 
Via Benzinga
Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
In a recent development in the health insurance sector, Cigna Corporation (NYSE: CI) has withdrawn from its proposed merger with Humana Inc. (NYSE: 
Via Benzinga
Humana, Comerica, Cleveland-Cliffs, And More: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Shannon Saccocia of Boston Private named iShares U.S. 
Via Benzinga
Cisco, Burlington Stores, Broadcom And More On CNBC's 'Final Trades'
It has been "a really tough year" for the healthcare sector. That's according to Shannon Saccocia of Boston Private, who appeared on CNBC’s "Halftime Report Final Trades." 
Via Benzinga
Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests to detect diseases sooner and personalize treatments. 
Via Benzinga
Exposures Product Safety
All eyes on the Fed as inflation metrics give mixed signals
Although the FOMC will almost certainly keep the Fed funds rate steady this week, investors aren’t yet convinced that the rate hike cycle has ended. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout
In our modern, high-speed society, many find themselves exhausted in the relentless chase for achievement. Yet, a concept from ancient China that dates back 2,000 years might offer a path to... 
Via Benzinga
4 Top-Ranked Sector ETFs To Buy In The Second Half
Investors could be well served by ETFs from sectors that house the top-ranked industries. 
Via Talk Markets
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
Via Benzinga
The 3 Most Promising Industries to Invest in for 2023’s Second Half
Discover the most promising industries to invest in. Unlock the top sectors for investing and seize lucrative opportunities. 
Via InvestorPlace
Stocks Flounder Despite Inflation Downtrend As Banking Crisis Emerges, But Outlook Remains Encouraging
Nothing goes in a straight line for long, and inflation is no different, i.e., the path is volatile, but disinflationary trends remain intact. 
Via Talk Markets
Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years. 
Via The Motley Fool
Uncertainties On Fed Policy, Geopolitics, And Earnings Cloud 2023 Outlook, But Trends Are Promising
The future direction of both stocks and bonds hinges on the trajectory of corporate earnings and interest rates, both of which are largely at the mercy of inflation, Fed monetary policy, and the state... 
Via Talk Markets
Worried About 2023? Here's a Safer Way to Invest in Stocks This Year
By holding a broad range of stocks and spreading out your investment over the year, you can minimize your overall risk. 
Via The Motley Fool
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.